| 11230526 |
Cylcoalkenyl derivatives useful as agonists of the GPR120 and/or GPR40 receptors |
Mark J. Macielag, Mark Wall, Michael Winters, Yue-Mei Zhang, Zhihua Sui |
2022-01-25 |
$277,663,000 |
| 10988433 |
Cyclohexyl GPR40 agonists for the treatment of type II diabetes |
Hui Huang, Sanath K. Meegalla, Mark R. Player |
2021-04-27 |
$133,106,000 |
| 9434688 |
Indole derivatives as selective androgen receptor modulators (SARMS) |
Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang |
2016-09-06 |
$91,731,000 |
| 9120830 |
2-substituted benzimidazoles as selective androgen receptor modulators (SARMS) |
Vernon Alford, Raymond Ng |
2015-09-01 |
$76,521,000 |
| 9062048 |
Cyclohexyl-azetidinyl antagonists of CCR2 |
Thomas P. Markotan, Nalin Subasinghe, Zhihua Sui |
2015-06-23 |
$67,203,000 |
| 8921559 |
4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2 |
Thomas P. Markotan, Nalin Subasinghe, Zhihua Sui, Xuqing Zhang |
2014-12-30 |
$83,373,000 |
| 8802865 |
2-substituted benzimidazoles as selective androgen receptor modulators (SARMS) |
Vernon Alford, Raymond Ng |
2014-08-12 |
$65,854,000 |
| 8765782 |
Indole derivatives as selective androgen receptor modulators (SARMS) |
Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang |
2014-07-01 |
$56,473,000 |
| 8586616 |
Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
Raymond Ng, Zhihua Sui, Jihua Guan, Vernon Alford |
2013-11-19 |
$94,994,000 |
| 8575206 |
2-substituted benzimidazoles as selective androgen receptor modulators (SARMS) |
Vernon Alford, Raymond Ng |
2013-11-05 |
$41,776,000 |
| 8518969 |
Cyclohexyl-azetidinyl antagonists of CCR2 |
Thomas P. Markotan, Nalin Subasinghe, Zhihua Sui |
2013-08-27 |
$41,522,000 |
| 8436023 |
Cyclohexyl-azetidinyl antagonists of CCR2 |
Xuqing Zhang, Zhihua Sui |
2013-05-07 |
$59,807,000 |
| 8394971 |
Indole derivatives as selective androgen receptor modulators (SARMS) |
Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang |
2013-03-12 |
$42,840,000 |
| 8269015 |
4-azetidinyl-1-heteroaryl-cyclohexane antagonists of CCR2 |
Xuqing Zhang, Heather Rae Hufnagel, Chaozhong Cai, Thomas P. Markotan, Zhihua Sui |
2012-09-18 |
$73,478,000 |
| 7968580 |
Imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS) |
Zhihua Sui |
2011-06-28 |
$35,084,000 |
| 7932399 |
2-substituted benzimidazoles as selective androgen receptor modulators (SARMS) |
Vernon Alford, Raymond Ng, Zhihua Sui |
2011-04-26 |
$123,467,000 |
| 7879895 |
Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
Raymond Ng, Zhihua Sui, Jihua Guan, Vernon Alford |
2011-02-01 |
$55,355,000 |
| 7795446 |
Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
Raymond Ng, Zhihua Sui, Jihua Guan, Vernon Alford |
2010-09-14 |
$62,961,000 |
| 7705147 |
Indole derivatives as selective androgen receptor modulators (SARMS) |
Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang |
2010-04-27 |
$68,299,000 |
| 7678926 |
Indole derivatives as selective androgen receptor modulators (SARMS) |
Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang |
2010-03-16 |
$119,247,000 |
| 7595409 |
3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers |
Zhihua Sui |
2009-09-29 |
$391,138,000 |
| 7566733 |
Benzimidazole derivatives useful as selective androgen receptor modulators (sarms) |
Raymond Ng, Zhihua Sui, Jihua Guan, Vernon Alford |
2009-07-28 |
$408,420,000 |
| 7531565 |
Imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS) |
Zhihua Sui |
2009-05-12 |
$286,070,000 |
| 7427682 |
Indole derivatives as selective androgen receptor modulators (SARMS) |
Zhihua Sui, James Fiordeliso, Weiqin Jiang, Xuqing Zhang |
2008-09-23 |
$476,683,000 |
| 7348438 |
Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS) |
Raymond Ng, Zhihua Sui, Jihua Guan, Vernon Alford |
2008-03-25 |
$249,076,000 |
